Neoadjuvant weekly paclitaxel and carboplatin with trastuzumab and pertuzumab in HER2-positive breast cancer: a Brown University Oncology Research Group (BrUOG) study von Lopresti, M. L., Bian, J. J., Sakr, B. J., Strenger, R. S., Legare, R. D., Fenton, M., Witherby, S. M., Dizon, D. S., Pandya, S. V., Stuckey, A. R., Edmondson, D. A., Gass, J. S., Emmick, C. M., Graves, T. A., Cutitar, M., Olszewski, A. J., Sikov, W. M.

Volltext

Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia von Song, Woo-Joo, Sullivan, Melanie G., Legare, Robert D., Hutchings, Sarah, Tan, Xiaolian, Kufrin, Dubravka, Ratajczak, Janina, Resende, Isabel C., Haworth, Catherine, Hock, Randy, Loh, Mignon, Felix, Carolyn, Roy, Denis-Claude, Busque, Lambert, Kurnit, David, Willman, Cheryl, Gewirtz, Alan M., Speck, Nancy A., Bushweller, John H., Li, Frederick P., Gardiner, Katheleen, Poncz, Mortimer, Maris, John M., Gilliland, D. Gary

Volltext

A Tyrosine Kinase Created by Fusion of the PDGFRA and FIP1L1 Genes as a Therapeutic Target of Imatinib in Idiopathic Hypereosinophilic Syndrome von Cools, Jan, DeAngelo, Daniel J, Gotlib, Jason, Stover, Elizabeth H, Legare, Robert D, Cortes, Jorges, Kutok, Jeffrey, Clark, Jennifer, Galinsky, Ilene, Griffin, James D, Cross, Nicholas C.P, Tefferi, Ayalew, Malone, James, Alam, Rafeul, Schrier, Stanley L, Schmid, Janet, Rose, Michal, Vandenberghe, Peter, Verhoef, Gregor, Boogaerts, Marc, Wlodarska, Iwona, Kantarjian, Hagop, Marynen, Peter, Coutre, Steven E, Stone, Richard, Gilliland, D. Gary

Volltext

PKC412 overcomes resistance to imatinib in a murine model of FIP1L1-PDGFRα-induced myeloproliferative disease von Cools, Jan, Stover, Elizabeth H, Boulton, Christina L, Gotlib, Jason, Legare, Robert D, Amaral, Sonia M, Curley, David P, Duclos, Nicole, Rowan, Rebecca, Kutok, Jeffery L, Lee, Benjamin H, Williams, Ifor R, Coutre, Steven E, Stone, Richard M, DeAngelo, Daniel J, Marynen, Peter, Manley, Paul W, Meyer, Thomas, Fabbro, Doriano, Neuberg, Donna, Weisberg, Ellen, Griffin, James D, Gilliland, D.Gary

Volltext

Linkage of a Familial Platelet Disorder With a Propensity to Develop Myeloid Malignancies to Human Chromosome 21q22.1-22.2 von Ho, Carolyn Y., Otterud, Brith, Legare, Robert D., Varvil, Tena, Saxena, Richa, DeHart, David B., Kohler, Susan E., Aster, Jon C., Dowton, S. Bruce, Li, Frederick P., Leppert, Mark, Gilliland, D. Gary

Volltext

CBFA2, frequently rearranged in leukemia, is not responsible for a familial leukemia syndrome von LEGARE, R. D, LU, D, GILLILAND, D. G, GALLAGHER, M, HO, C, TAN, X, BARKER, G, SHIMIZU, K, OHKI, M, LENNY, N, HIEBERT, S

Volltext

Neoadjuvant weekly paclitaxel and carboplatin with trastuzumab and pertuzumab in HER2-positive breast cancer: a Brown University Oncology Research Group von Fenton, M, Sakr, B. J, Witherby, S. M, Bian, J. J, Strenger, R. S, Lopresti, M. L, Legare, R. D

Volltext

Abstract P5-09-16: Multiple mutations in a single lineage: is it time for a shift in predictive testing? von Scalia Wilbur, J, Laprise, J, Beaston, M, Legare, RD

Volltext

Abstract P6-06-03: Novel hereditary breast cancer gene mutations: Should there be greater concern regarding ovarian cancer risk? von Nassikas, N, Wilbur, JS, Laprise, JK, Legare, RD

Volltext

Is tumor board relevant? von Dizon, D. S., Gass, J., Legare, R. D., Sakr, B. J., Rizack, T.

Volltext

Myelodysplastic syndrome von Legare, Robert D, Gilliland, Gary D

Volltext

The importance of continued surveillance of high risk cancer families as illustrated in a family with Gardner’s syndrome von Legare, R. D., Scalia-Wilbur, J., Kent, J.

Volltext

Prediction of therapy‐related acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS) after autologous bone marrow transplant (ABMT) for lymphoma von Legare, Robert D., Gribben, John G., Maragh, Marlon, Hermanowski‐Vosatka, Anne, Roach, Sheila, Tantravahi, Ramana, Nadler, Lee M., Gilliland, D. Gary

Volltext

Neoadjuvant therapy for stage II-III breast cancer with weekly nab-paclitaxel, every-three-week carboplatin, and targeted agents: Interim dose delivery and toxicity data von Rizack, T., Abu-Khalaf, M. M., Legare, R. D., Strenger, R., Fenton, M. A., Sakr, B. J., Kennedy, T. A., Harris, L., Sikov, W. M.

Volltext

Predictive Value of Clonality Assays in Patients With Non-Hodgkin's Lymphoma Undergoing Autologous Bone Marrow Transplant: A Single Institution Study von Mach-Pascual, Sara, Legare, Robert D., Lu, Doanh, Kroon, Mary, Neuberg, Donna, Tantravahi, Ramana, Stone, Richard M., Freedman, Arnold S., Nadler, Lee M., Gribben, John G., Gilliland, D. Gary

Volltext

Cross-sensitivity between paclitaxel and docetaxel in a women's cancers program von Dizon, Don S., Schwartz, Joanna, Rojan, Adam, Miller, Jane, Pires, Leslie, DiSilvestro, Paul, Gordinier, Mary E., Moore, Richard, Granai, Cornelius O., Legare, Robert D.

Volltext

Assessing personal and family history characteristics of patients seeking cancer risk assessment due to direct-to-consumer marketing in a high risk clinic von Legare, RD, Kent, JL, Wilbur, JS

Volltext

Cross-sensitivity between paclitaxel and docetaxel in a women’s cancers program von Dizon, D. S., Rojan, A., Miller, J., Schwartz, J., Gordinier, M. E., Pires, L., Disilvestro, P., Moore, R., Granai, C. O., Gass, J., Legare, R. D.

Volltext

Predictive Value of Clonality Assays in Patients With Non-Hodgkin's Lymphoma Undergoing Autologous Bone Marrow Transplant: A Single Institution Study von Mach-Pascual, Sara, Legare, Robert D., Lu, Doanh, Kroon, Mary, Neuberg, Donna, Tantravahi, Ramana, Stone, Richard M., Freedman, Arnold S., Nadler, Lee M., Gribben, John G., Gilliland, D. Gary

Volltext

Attosecond-resolved photoionization of chiral molecules von Beaulieu, S., Comby, A., Clergerie, A., Caillat, J., Descamps, D., Dudovich, N., Fabre, B., Géneaux, R., Légaré, F., Petit, S., Pons, B., Porat, G., Ruchon, T., Taïeb, R., Blanchet, V., Mairesse, Y.

Volltext